Advertisement
Screener

LABCORP HOLDINGS INC. (LH) Cash and Cash Equivalents, Period Increase (Decrease)

2.5 / 5 stars · 59/120 Roast Me

LABCORP HOLDINGS INC. Cash and Cash Equivalents, Period Increase (Decrease)

LABCORP HOLDINGS INC. (LH) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$89.30 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-02-28

  • LABCORP HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was -$23.60M.
  • LABCORP HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $95.70M, a 85.74% decline year-over-year.
  • LABCORP HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$83.40M.
  • LABCORP HOLDINGS INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was -$78.00M, a 272.95% decline year-over-year.
  • LABCORP HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$89.30M, a 181.03% decline from fiscal 2018.
  • LABCORP HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $110.20M.
  • LABCORP HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$116.90M.
  • LABCORP HOLDINGS INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$282.80M, a 307.33% decline from fiscal 2015.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 3 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 6 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 9 month as first filedCash and Cash Equivalents, Period Increase (Decrease) 12 month
2019-12-31-$23.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$72.10M
derived: sum of 2 quarters · filed 2020-02-28
-$11.30M
derived: sum of 3 quarters · filed 2020-02-28
-$89.30M
10-K · filed 2020-02-28
2019-09-30$95.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$12.30M
derived: sum of 2 quarters · filed 2019-10-31
-$65.70M
10-Q · filed 2019-10-31
-$531.50M
derived: sum of 4 quarters · filed 2020-02-28
2019-06-30-$83.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$161.40M
10-Q · filed 2019-08-08
-$627.20M
derived: sum of 3 quarters · filed 2020-02-28
$44.00M
derived: sum of 4 quarters · filed 2020-02-28
2019-03-31-$78.00M
10-Q · filed 2019-05-03
-$543.80M
derived: sum of 2 quarters · filed 2020-02-28
$127.40M
derived: sum of 3 quarters · filed 2020-02-28
-$12.90M
derived: sum of 4 quarters · filed 2020-02-28
2018-12-31-$465.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$205.40M
derived: sum of 2 quarters · filed 2020-02-28
$65.10M
derived: sum of 3 quarters · filed 2020-02-28
$110.20M
10-K · filed 2020-02-28
2018-09-30$671.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
$530.90M
derived: sum of 2 quarters · filed 2019-10-31
$576.00M
10-Q · filed 2019-10-31
$483.60M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30-$140.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$95.20M
10-Q · filed 2019-08-08
-$187.60M
derived: sum of 3 quarters · filed 2020-02-28
-$78.30M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$45.10M
10-Q · filed 2019-05-03
-$47.30M
derived: sum of 2 quarters · filed 2020-02-28
$62.00M
derived: sum of 3 quarters · filed 2020-02-28
-$3.70M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31-$92.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$16.90M
derived: sum of 2 quarters · filed 2020-02-28
-$48.80M
derived: sum of 3 quarters · filed 2020-02-28
-$116.90M
10-K · filed 2020-02-28
2017-09-30$109.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30
$43.60M
derived: sum of 2 quarters · filed 2018-10-30
-$24.50M
10-Q · filed 2018-10-30
-$24.30M
10-Q · filed 2017-11-02
-$158.50M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$65.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27
-$133.80M
10-Q · filed 2018-07-27
-$133.70M
10-Q · filed 2017-08-02
-$267.80M
derived: sum of 3 quarters · filed 2019-02-28
-$339.80M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$68.10M
10-Q · filed 2018-05-01
-$202.10M
derived: sum of 2 quarters · filed 2019-02-28
-$274.10M
derived: sum of 3 quarters · filed 2019-02-28
-$330.80M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$134.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
-$206.00M
derived: sum of 2 quarters · filed 2019-02-28
-$262.70M
derived: sum of 3 quarters · filed 2019-02-28
-$282.80M
10-K · filed 2019-02-28
2016-09-30-$72.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$128.70M
derived: sum of 2 quarters · filed 2017-11-02
-$148.80M
10-Q · filed 2017-11-02
-$145.40M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$56.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
-$76.80M
10-Q · filed 2017-08-02
-$73.40M
derived: sum of 3 quarters · filed 2018-02-27
$59.60M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$20.10M
10-Q · filed 2017-04-28
-$16.70M
derived: sum of 2 quarters · filed 2018-02-27
$116.30M
derived: sum of 3 quarters · filed 2018-02-27
$155.30M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$136.40M
derived: sum of 2 quarters · filed 2018-02-27
$175.40M
derived: sum of 3 quarters · filed 2018-02-27
$136.40M
10-K · filed 2018-02-27
2015-09-30$133.00M
10-Q · filed 2016-10-28
$172.00M
derived: sum of 2 quarters · filed 2016-10-28
$133.00M
10-Q · filed 2015-10-30
$42.70M
derived: sum of 4 quarters · filed 2016-10-28
2015-06-30$39.00M
10-Q · filed 2016-07-29
$39.00M
10-Q · filed 2015-07-30
-$90.30M
derived: sum of 3 quarters · filed 2016-07-29
$5.90M
derived: sum of 4 quarters · filed 2016-07-29
2015-03-31-$133.60M
10-Q · filed 2016-05-06
-$129.30M
derived: sum of 2 quarters · filed 2016-05-06
-$33.10M
derived: sum of 3 quarters · filed 2016-05-06
-$133.60M
derived: sum of 4 quarters · filed 2016-05-06
2014-12-31$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
$100.50M
derived: sum of 2 quarters · filed 2016-03-01
$0.00
derived: sum of 3 quarters · filed 2016-03-01
$176.00M
10-K · filed 2016-03-01
2014-09-30$96.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30
-$4.30M
derived: sum of 2 quarters · filed 2015-10-30
$171.70M
10-Q · filed 2015-10-30
$401.60M
derived: sum of 4 quarters · filed 2017-02-27
2014-06-30-$100.50M
derived: 10-Q 6 month − 10-K 3 month · filed 2015-07-30
$75.50M
10-Q · filed 2015-07-30
$305.40M
derived: sum of 3 quarters · filed 2017-02-27
$368.20M
derived: sum of 4 quarters · filed 2017-02-27
2014-03-31$176.00M
10-K · filed 2017-02-27
-$65.10M
10-Q · filed 2014-04-29
$405.90M
derived: sum of 2 quarters · filed 2017-02-27
$468.70M
derived: sum of 3 quarters · filed 2017-02-27
$394.20M
derived: sum of 4 quarters · filed 2017-02-27
2013-12-31$229.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01
$292.70M
derived: sum of 2 quarters · filed 2016-03-01
$218.20M
derived: sum of 3 quarters · filed 2016-03-01
-$62.80M
10-K · filed 2016-03-01
2013-09-30$62.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
-$11.70M
derived: sum of 2 quarters · filed 2014-11-10
-$292.70M
10-Q · filed 2014-11-10
-$291.90M
derived: sum of 4 quarters · filed 2015-02-26
2013-06-30-$74.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29
-$355.50M
10-Q · filed 2014-07-29
-$354.70M
derived: sum of 3 quarters · filed 2015-02-26
-$13.10M
derived: sum of 4 quarters · filed 2015-02-26
2013-03-31-$281.00M
10-Q · filed 2014-04-29
-$280.20M
derived: sum of 2 quarters · filed 2015-02-26
$61.40M
derived: sum of 3 quarters · filed 2015-02-26
$55.90M
derived: sum of 4 quarters · filed 2015-02-26
2012-12-31$800.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26
$342.40M
derived: sum of 2 quarters · filed 2015-02-26
$336.90M
derived: sum of 3 quarters · filed 2015-02-26
$307.50M
10-K · filed 2015-02-26
2012-09-30$341.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28
$336.10M
derived: sum of 2 quarters · filed 2013-10-28
$306.70M
10-Q · filed 2013-10-28
$380.20M
derived: sum of 4 quarters · filed 2014-02-25
2012-06-30-$5.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-30
-$34.90M
10-Q · filed 2013-07-30
$38.60M
derived: sum of 3 quarters · filed 2014-02-25
$5.50M
derived: sum of 4 quarters · filed 2014-02-25
2012-03-31-$29.40M
10-Q · filed 2013-05-01
$44.10M
derived: sum of 2 quarters · filed 2014-02-25
$11.00M
derived: sum of 3 quarters · filed 2014-02-25
-$65.50M
derived: sum of 4 quarters · filed 2014-02-25
2011-12-31$73.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25
$40.40M
derived: sum of 2 quarters · filed 2014-02-25
-$36.10M
derived: sum of 3 quarters · filed 2014-02-25
-$71.40M
10-K · filed 2014-02-25
2011-09-30-$33.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-30
-$109.60M
derived: sum of 2 quarters · filed 2012-10-30
-$144.90M
10-Q · filed 2012-10-30
-$11.10M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30-$76.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
-$111.80M
10-Q · filed 2012-08-02
$22.00M
derived: sum of 3 quarters · filed 2013-02-26
$15.10M
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31-$35.30M
10-Q · filed 2012-04-27
$98.50M
derived: sum of 2 quarters · filed 2013-02-26
$91.60M
derived: sum of 3 quarters · filed 2013-02-26
$23.20M
derived: sum of 4 quarters · filed 2013-02-26
2010-12-31$133.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$126.90M
derived: sum of 2 quarters · filed 2013-02-26
$58.50M
derived: sum of 3 quarters · filed 2013-02-26
$82.20M
10-K · filed 2013-02-26
2010-09-30-$6.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31
-$75.30M
derived: sum of 2 quarters · filed 2011-10-31
-$51.60M
10-Q · filed 2011-10-31
-$29.90M
derived: sum of 4 quarters · filed 2012-02-24
2010-06-30-$68.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-02
-$44.70M
10-Q · filed 2011-08-02
-$23.00M
derived: sum of 3 quarters · filed 2012-02-24
-$122.80M
derived: sum of 4 quarters · filed 2012-02-24
2010-03-31$23.70M
10-Q · filed 2011-05-04
$45.40M
derived: sum of 2 quarters · filed 2012-02-24
-$54.40M
derived: sum of 3 quarters · filed 2012-02-24
-$201.00M
derived: sum of 4 quarters · filed 2012-02-24
2009-12-31$21.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
-$78.10M
derived: sum of 2 quarters · filed 2012-02-24
-$224.70M
derived: sum of 3 quarters · filed 2012-02-24
-$71.20M
10-K · filed 2012-02-24
2009-09-30-$99.80M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-01
-$246.40M
derived: sum of 2 quarters · filed 2010-11-01
-$92.90M
10-Q · filed 2010-11-01
$77.40M
derived: sum of 4 quarters · filed 2011-03-07
2009-06-30-$146.60M
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2010-08-20
$6.90M
10-Q/A · filed 2010-08-20
$177.20M
derived: sum of 3 quarters · filed 2011-03-07
$71.30M
derived: sum of 4 quarters · filed 2011-03-07
2009-03-31$153.50M
10-Q · filed 2010-04-28
$323.80M
derived: sum of 2 quarters · filed 2011-03-07
$217.90M
derived: sum of 3 quarters · filed 2011-03-07
2008-12-31$170.30M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2011-03-07
$64.40M
derived: sum of 2 quarters · filed 2011-03-07
$163.30M
10-K/A · filed 2011-03-07
2008-09-30-$105.90M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2009-10-29
-$7.00M
10-Q · filed 2009-10-29
2008-06-30$98.90M
10-Q/A · filed 2009-08-28
2007-12-31$4.90M
10-K · filed 2010-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
QUEST DIAGNOSTICS INC (DGX)United States$26.096B22.09
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30